A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)

NCT00592111 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Pediatric
Hodgkin's Disease

Interventions

DRUG: COPP/ABV
DRUG: COPP/ABV
DRUG: intensive chemo with concurrent growth factor

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]